Beijing Winsunny Pharmaceutical CO.LTD Total Liabilities

Latest as of June 2025: CN¥1.10 Billion CNY ≈ $161.06 Million USD

Beijing Winsunny Pharmaceutical CO.LTD total liabilities. Based on the latest financial reports, Beijing Winsunny Pharmaceutical CO.LTD (601089) has total liabilities worth CN¥1.10 Billion CNY (≈ $161.06 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Beijing Winsunny Pharmaceutical CO.LTD to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)

Total liabilities of Beijing Winsunny Pharmaceutical CO.LTD from 2020 to 2024. This chart illustrates how Beijing Winsunny Pharmaceutical CO.LTD's total liabilities have evolved over time, based on quarterly financial data.

Beijing Winsunny Pharmaceutical CO.LTD Competitors by Total Liabilities

The table below lists competitors of Beijing Winsunny Pharmaceutical CO.LTD ranked by their total liabilities.

Company	Country	Total Liabilities
Bank Islam Malaysia Bhd KLSE:5258	Malaysia	RM94.68 Billion
Hunan Oil Pump SHG:603319	China	CN¥1.72 Billion
S.ENER.ELEC.SP.GDR REGS 1 F:ECEA	Germany	€8.78 Billion
PORR AG VI:POS	Austria	€3.57 Billion
Bowhead Specialty Holdings Inc. NYSE:BOW	USA	$2.21 Billion
Nanfang Pump Industry SHE:300145	China	CN¥4.97 Billion
Ayalon Holdings Ltd TA:AYAL	Israel	ILA19.91 Billion
Electro Optic Systems Holdings Ltd AU:EOS	Australia	AU$136.69 Million

Liability Composition Analysis (2020–2024)

This chart breaks down Beijing Winsunny Pharmaceutical CO.LTD's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 601089 current and non-current assets.

Liquidity & Leverage Metrics

Beijing Winsunny Pharmaceutical CO.LTD Total Liabilities Ratios Explained

Beijing Winsunny Pharmaceutical CO.LTD total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.73	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.31	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.23	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing Winsunny Pharmaceutical CO.LTD's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)

The table below shows the annual total liabilities of Beijing Winsunny Pharmaceutical CO.LTD from 2020 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.26 Billion ≈ $184.46 Million	+17.67%
2023-12-31	CN¥1.07 Billion ≈ $156.76 Million	-6.28%
2022-12-31	CN¥1.14 Billion ≈ $167.26 Million	+21.87%
2021-12-31	CN¥937.86 Million ≈ $137.24 Million	+32.28%
2020-12-31	CN¥709.01 Million ≈ $103.75 Million	--

About Beijing Winsunny Pharmaceutical CO.LTD

SHG:601089 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.10 Billion

CN¥7.53 Billion CNY

Market Cap Rank

#8173 Global

#1846 in China

Share Price

CN¥15.69

Change (1 day)

-0.63%

52-Week Range

CN¥14.95 - CN¥30.27

All Time High

CN¥31.88